Tel Aviv Sourasky Medical Center (Ichilov)

The Tel Aviv Sourasky Medical Center (TASMC) is the largest acute care facility in Israel and a leader across the spectrum of healthcare nationally and internationally. Spanning a campus of over 2.7 million square feet (250,000 square meters), with 1500 patient beds and 8,000 employees, this governmental academic medical center is the only medical tertiary facility in Tel Aviv. Every day, the Medical Center serves a population of over one million residents, tourists and commuters in the greater Tel Aviv area, and opens its doors to patients from throughout Israel and the world.

TASMC is at the heart of our Start-up Nation, both in terms of our leadership position in the country and our location at the epicenter of high tech in central Israel. The city of Tel Aviv has Israel’s highest density of start-up and biotech initiatives, hosting R&D centers for many of the world’s largest tech firms. The city has a vested interest in partnership development, company success, and accelerated solution delivery. As such, we feel a strong sense of commitment to be the pioneering force in medical and technological innovation and discovery.

Vision

The Tel Aviv Sourasky Medical Center is committed to medical excellence and compassionate care with the best medical teams treating every patient equally while integrating excellence in academics and R&D to the benefit of Israel’s residents and the population worldwide.

 

At the forefront – nationally and internationally

Tel Aviv Sourasky Medical Center has a well-deserved reputation as a national referral center across a wide range of medical and surgical disciplines.
Medical and scientific talent and advanced research programs have earned the Medical Center many prestigious international awards as well as accolades for research discoveries and treatment solutions.
Driven to confront medicine’s most intriguing challenges, researchers at Tel Aviv Sourasky Medical Center have made great strides in clinical and scientific insights and solutions.
The Medical Center leads over 2,000 concurrent clinical studies, submitting for review over 600 new clinical trial protocols each year. In Israel, TASMC is the clinical trial site of choice by global pioneering pharmaceutical companies. At every turn, revolutionary systems are being introduced to propel scientific insights and treatments forward. TASMC clinicians and scientists have been the first to develop and institute new treatments and technologies to the world, such as first-ever genetically engineered immunotherapy for cancer, awake brain surgeries, and 3D printing, to name just a few. The Medical Center boasts collaborations with prominent academic, governmental, public, and private organizations around the globe, including local world-class education and research institutions. Dozens of pioneering companies have strategic agreements with the Medical Center.